Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment

Medical Xpress - latest medical and health news stories · 1h ago

The New England Journal of Medicine has published a study on the long-term efficacy of AAV8-mediated gene therapy (GNT0003) in patients with Crigler-Najjar syndrome, an extremely rare congenital liver disorder affecting approximately 500 people in Europe. It is caused by a deficiency of UGT1A1, an enzyme required for bilirubin metabolism. The accumulation of this substance can lead to…

Read original article on Medical Xpress - latest medical and health news stories →

Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment

Related news